Alternative modalities of administering amphotericin B: current issues
- 31 May 1994
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 28, 51-56
- https://doi.org/10.1016/s0163-4453(94)95986-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodentsJournal of Antimicrobial Chemotherapy, 1991
- Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trialJournal of Antimicrobial Chemotherapy, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Treatment of systemic fungal infections with liposomal amphotericin BArchives of internal medicine (1960), 1989
- Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infectionsEuropean Journal of Cancer and Clinical Oncology, 1988
- Liposomes as carriers of antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1987
- Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin BThe Journal of Infectious Diseases, 1983
- Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis1American Review of Respiratory Disease, 1982